Top Markets
Coin of the day
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336
Clasificación en acciones #3340
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Precio por acción
$6.23
Capitalización bursátil
$5.58B
Cambio (1 día)
-1.10%
Cambio (1 año)
25.53%
País
CN
Comercio Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

Categoría

Historial del precio de la acción de Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Precio más alto de cierre: $6.78 el 2026-08-01

Precio más bajo de cierre: $4.81 el 2020-07-01
Historial del precio de la acción de Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd desde 2020 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 5.67%
2025 188.76%
2024 -5.91%
2023 62.34%
2022 -30.84%
2021 -25.95%
2020 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$772.27 7.33%
CH